NO20080125L - 2,6-kinolinylderivater, fremgangsmater for fremstilling derav og deres anvendelse som medikament - Google Patents

2,6-kinolinylderivater, fremgangsmater for fremstilling derav og deres anvendelse som medikament

Info

Publication number: NO20080125L
Authority: NO; Norway
Prior art keywords: processes; preparation; medicament; quinolinyl derivatives; diseases including
Prior art date: 2005-06-09

Application number

NO20080125A

Other languages

English (en)

Norwegian (no)

Inventor

Benjamin Perry

Original Assignee

Ucb Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-09

Filing date

2008-01-08

Publication date

2008-01-08

2005-06-09 Priority claimed from GB0511781A external-priority patent/GB0511781D0/en

2006-01-06 Priority claimed from GB0600213A external-priority patent/GB0600213D0/en

2008-01-08 Application filed by Ucb Pharma Sa filed Critical Ucb Pharma Sa

2008-01-08 Publication of NO20080125L publication Critical patent/NO20080125L/no

Links

238000000034 method Methods 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
201000004624 Dermatitis Diseases 0.000 abstract 3
208000011231 Crohn disease Diseases 0.000 abstract 2
201000001320 Atherosclerosis Diseases 0.000 abstract 1
206010010741 Conjunctivitis Diseases 0.000 abstract 1
208000004262 Food Hypersensitivity Diseases 0.000 abstract 1
206010016946 Food allergy Diseases 0.000 abstract 1
208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
208000003251 Pruritus Diseases 0.000 abstract 1
201000004681 Psoriasis Diseases 0.000 abstract 1
206010039085 Rhinitis allergic Diseases 0.000 abstract 1
208000024780 Urticaria Diseases 0.000 abstract 1
201000010105 allergic rhinitis Diseases 0.000 abstract 1
208000006673 asthma Diseases 0.000 abstract 1
208000010668 atopic eczema Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
235000020932 food allergy Nutrition 0.000 abstract 1
239000008177 pharmaceutical agent Substances 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
201000009890 sinusitis Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Vascular Medicine (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20080125A 2005-06-09 2008-01-08 2,6-kinolinylderivater, fremgangsmater for fremstilling derav og deres anvendelse som medikament NO20080125L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0511781A GB0511781D0 (en)	2005-06-09	2005-06-09	2,6-quinolinyl derivatives, processes for preparing them and their uses
US20615805A	2005-08-18	2005-08-18
GB0600213A GB0600213D0 (en)	2006-01-06	2006-01-06	2,6-quinolinyl derivatives, processes for preparing them and their uses
PCT/EP2006/004811 WO2006131200A1 (en)	2005-06-09	2006-05-22	2,6 quinolinyl derivatives, processes for preparing them and their use as medicament

Publications (1)

Publication Number	Publication Date
NO20080125L true NO20080125L (no)	2008-01-08

Family

ID=36968449

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20080125A NO20080125L (no)	2005-06-09	2008-01-08	2,6-kinolinylderivater, fremgangsmater for fremstilling derav og deres anvendelse som medikament

Country Status (19)

Country	Link
US (1)	US7732614B2 (de)
EP (1)	EP1902045B1 (de)
JP (1)	JP2008542407A (de)
KR (1)	KR20080021085A (de)
AR (1)	AR054129A1 (de)
AT (1)	ATE496041T1 (de)
AU (1)	AU2006254772B2 (de)
BR (1)	BRPI0611243A2 (de)
CA (1)	CA2610800A1 (de)
DE (1)	DE602006019731D1 (de)
EA (1)	EA013080B1 (de)
IL (1)	IL187235A0 (de)
MX (1)	MX2007014721A (de)
MY (1)	MY140739A (de)
NO (1)	NO20080125L (de)
NZ (1)	NZ563739A (de)
PE (1)	PE20070081A1 (de)
TW (1)	TW200716605A (de)
WO (1)	WO2006131200A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7638630B2 (en)	2002-04-30	2009-12-29	Ucb Pharma S.A.	2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
CA2478458A1 (en) *	2004-08-20	2006-02-20	Michael Panzara	Treatment of pediatric multiple sclerosis
CA2587597A1 (en) *	2004-11-19	2006-05-26	Biogen Idec Ma Inc.	Treatment for multiple sclerosis
EA013080B1 (ru)	2005-06-09	2010-02-26	Юсб Фарма С.А.	2,6-хинолинильные производные, способы их получения и их применение
WO2008125215A1 (en) *	2007-04-12	2008-10-23	Ucb Pharma, S.A.	Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses
JP2013525260A (ja) *	2009-04-17	2013-06-20	バイオジェン・アイデック・エムエイ・インコーポレイテッド	急性骨髄性白血病を治療するための組成物および方法
HRP20171045T1 (hr)	2010-04-16	2017-10-06	Biogen Ma Inc.	Protutijela anti-vla-4
MY160723A (en) *	2013-12-30	2017-03-15	Univ Putra Malaysia	An anticoagulant
USD812958S1 (en)	2016-06-08	2018-03-20	Samsung Electronics Co., Ltd.	Cooktop
WO2018119142A1 (en)	2016-12-21	2018-06-28	Amgen Inc.	Anti-tnf alpha antibody formulations
EP3773573B1 (de)	2018-04-12	2026-03-18	Morphic Therapeutic, Inc.	Antagonisten von humanem integrin (alpha4) (beta7)
CN119080931A (zh)	2018-06-04	2024-12-06	马萨诸塞州渤健公司	具有降低的效应功能的抗vla-4抗体
ES3013256T3 (en)	2018-10-30	2025-04-11	Gilead Sciences Inc	Imidazo[1,2-a]pyridine derivatives as alpha4beta7 integrin inhibitors for the treatment of inflammatory diseases
FI3873884T3 (fi) *	2018-10-30	2025-02-24	Gilead Sciences Inc	3-(kinolin-8-yyli)-1,4-dihydropyrido[3,4-d]pyrimidiini-2,4-dionijohdannaisia alfa-4-beta-7-integriinin estäjinä tulehdussairauksien hoidossa
JP7189368B2 (ja) *	2018-10-30	2022-12-13	ギリアードサイエンシーズ，インコーポレイテッド	アルファ４ベータ７インテグリンの阻害のための化合物
EP3873605B1 (de) *	2018-10-30	2024-10-23	Gilead Sciences, Inc.	Verbindungen zur inhibierung von alpha4-beta7-integrin
WO2021030438A1 (en)	2019-08-14	2021-02-18	Gilead Sciences, Inc.	Compounds for inhibition of alpha 4 beta 7 integrin
TWI775182B (zh)	2019-10-16	2022-08-21	美商莫菲克醫療股份有限公司	抑制人類整合素αβ
WO2025106410A1 (en) *	2023-11-15	2025-05-22	Dice Molecules Sv, Inc.	Alpha 4 beta 7 integrin modulators and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69528197T2 (de)	1994-12-14	2003-06-05	Santen Pharmaceutical Co., Ltd	Neue 1,3-dialkylharnstoff-derivate
EP1005445B1 (de)	1997-08-22	2004-05-26	F. Hoffmann-La Roche Ag	N-alkanoylphenylalaninderivate
US6608084B1 (en)	1998-08-26	2003-08-19	Aventis Pharma Ltd.	Aza-bicycles which modulate the inhibition of cell adhesion
JP2002543194A (ja)	1999-04-28	2002-12-17	ドクター・レディーズ・ラボラトリーズ・リミテッド	置換二環系ヘテロ環化合物、その製造方法、並びに抗肥満症及び抗高コレステロール血症剤としてのこれらの使用
MY129000A (en)	2000-08-31	2007-03-30	Tanabe Seiyaku Co	INHIBITORS OF a4 MEDIATED CELL ADHESION
MY140707A (en)	2002-02-28	2010-01-15	Mitsubishi Tanabe Pharma Corp	Process for preparing a phenylalanine derivative and intermediates thereof
US7638630B2 (en) *	2002-04-30	2009-12-29	Ucb Pharma S.A.	2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
US7153870B2 (en)	2003-07-25	2006-12-26	Pfizer Inc.	Nicotinamide derivatives useful as PDE4 inhibitors
GB0329584D0 (en)	2003-12-20	2004-01-28	Tanabe Seiyaku Co	Novel compounds
EA013080B1 (ru)	2005-06-09	2010-02-26	Юсб Фарма С.А.	2,6-хинолинильные производные, способы их получения и их применение

2006
- 2006-05-22 EA EA200702589A patent/EA013080B1/ru not_active IP Right Cessation
- 2006-05-22 WO PCT/EP2006/004811 patent/WO2006131200A1/en not_active Ceased
- 2006-05-22 MX MX2007014721A patent/MX2007014721A/es active IP Right Grant
- 2006-05-22 BR BRPI0611243-9A patent/BRPI0611243A2/pt not_active IP Right Cessation
- 2006-05-22 EP EP06753758A patent/EP1902045B1/de active Active
- 2006-05-22 DE DE602006019731T patent/DE602006019731D1/de active Active
- 2006-05-22 AT AT06753758T patent/ATE496041T1/de not_active IP Right Cessation
- 2006-05-22 CA CA002610800A patent/CA2610800A1/en not_active Abandoned
- 2006-05-22 JP JP2008515081A patent/JP2008542407A/ja active Pending
- 2006-05-22 AU AU2006254772A patent/AU2006254772B2/en not_active Ceased
- 2006-05-22 KR KR1020077031009A patent/KR20080021085A/ko not_active Withdrawn
- 2006-05-22 MY MYPI20062356A patent/MY140739A/en unknown
- 2006-05-22 AR ARP060102077A patent/AR054129A1/es not_active Application Discontinuation
- 2006-05-22 NZ NZ563739A patent/NZ563739A/en not_active IP Right Cessation
- 2006-06-02 PE PE2006000596A patent/PE20070081A1/es not_active Application Discontinuation
- 2006-06-05 TW TW095119798A patent/TW200716605A/zh unknown
- 2006-06-09 US US11/450,694 patent/US7732614B2/en not_active Expired - Fee Related
2007
- 2007-11-08 IL IL187235A patent/IL187235A0/en unknown
2008
- 2008-01-08 NO NO20080125A patent/NO20080125L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2006254772B2 (en)	2011-06-02
NZ563739A (en)	2009-12-24
JP2008542407A (ja)	2008-11-27
PE20070081A1 (es)	2007-02-15
MX2007014721A (es)	2008-02-14
IL187235A0 (en)	2008-02-09
TW200716605A (en)	2007-05-01
EP1902045A1 (de)	2008-03-26
US7732614B2 (en)	2010-06-08
US20070004775A1 (en)	2007-01-04
EA013080B1 (ru)	2010-02-26
EA200702589A1 (ru)	2008-06-30
AR054129A1 (es)	2007-06-06
BRPI0611243A2 (pt)	2010-08-24
AU2006254772A1 (en)	2006-12-14
KR20080021085A (ko)	2008-03-06
MY140739A (en)	2010-01-15
EP1902045B1 (de)	2011-01-19
ATE496041T1 (de)	2011-02-15
CA2610800A1 (en)	2006-12-14
DE602006019731D1 (de)	2011-03-03
WO2006131200A1 (en)	2006-12-14

Legal Events

Date	Code	Title	Description
2011-12-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20080125L (no)	2008-01-08	2,6-kinolinylderivater, fremgangsmater for fremstilling derav og deres anvendelse som medikament
SG155943A1 (en)	2009-10-29	Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
NO20045234L (no)	2005-01-18	2,6-kinolinyl- og 2,6-naftylderivater, fremgangsmate for fremstilling av disse, og anvendelse av disse som VLA-4-inhibitorer
ME01515B (me)	2014-04-20	PIRIMIDINSKI DERIVATI ZA TRETMAN ASTME, HOBP, ALERGIJSKOG RINITISA, ALERGIJSKOG KONJUNKTIVITISA, ATOPIČNOG DERMATITISA, RAKA, HEPATITISA B, HEPATITISA C, HIV-a, HPV-a, BAKTERIJSKIH INFEKCIJA I DERMATOZE
NO20081211L (no)	2008-05-08	Xantinderivater som selektive HM74A agonister
HRP20050318A2 (en)	2006-07-31	Pyrimidinone derivatives as therapeutic agents against acute and chronic inflamatory, ischaemic and remodelling processes
NO20074207L (no)	2007-10-26	Substituted pyrido(2,3-d) pyrimidine derivatives and pharmaceutical compositions useful as medicines for the treatment of autoimmune disorders
NO20084540L (no)	2008-10-28	Benzoimidazol-2-ylpyrimidiner og -pyraziner som modulatorer av histamin H4-reseptoren
NO20083427L (no)	2008-10-14	Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
DE602007008859D1 (de)	2010-10-14	Benzoimidazol-2-yl pyridine als modulatoren des histamin-h4-rezeptors
MX2009008787A (es)	2010-02-15	Moduladores 2-aminopirimidina del receptor de histamina h4.
NO20083919L (no)	2008-12-19	Pyridin- og pyrimidinderivater som mGluR2-antagonister
ATE457311T1 (de)	2010-02-15	Als inhibitoren von proteinkinasen geeignete aminopyridine und aminopyrimidine
NO20082673L (no)	2008-07-23	Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
NO20052076L (no)	2005-04-27	Fuserte azol-pyrimidinderivater.
WO2005021515A3 (en)	2005-08-25	Inhibitors of phosphodiesterase type-iv
NO20090268L (no)	2009-03-06	Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor
NO20083358L (no)	2008-09-30	Piperasinyl derivater som modulatorer for kjemokine reseptor aktivitet
NO20080408L (no)	2008-03-25	Azaindazolforbindelser og anvendelse derav
NO20074959L (no)	2007-10-02	Substituerte pyridinderivater
BR112013029862A2 (pt)	2016-12-20	derivados de piridin-2 (1h)-ona úteis como medicamentos para o tratamento de distúrbios mieloproliferativos, rejeição a transplante, doenças imunomediadas e inflamatórias
NO20085212L (no)	2009-01-12	Nye pyridinanaloger
MX2007008924A (es)	2007-08-21	Compuestos quimicos.
NO20082684L (no)	2008-08-15	F-, G-, H-, I- og K-krystallformer av imatinibmesylat
BR112013005622A2 (pt)	2016-05-03	heteroaril metil amidas